NCT03597464View on ClinicalTrials.gov

Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin

PHASE3CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

September 29, 2019

Primary Completion Date

October 7, 2021

Study Completion Date

October 7, 2021

Conditions
Lupus Nephritis
Interventions
DRUG

Voclosporin

Calcineurin inhibitor, oral, 23.7 mg twice daily (BID)

DRUG

Placebo Oral Capsule

Voclosporin placebo, oral, 3 capsules twice daily (BID)

Trial Locations (1)

73104

AURORA Investigative Center, Oklahoma City

Sponsors
All Listed Sponsors
lead

Aurinia Pharmaceuticals Inc.

INDUSTRY